Skip to main content
  • Home
  • Royal Marsden Hospital
Institutional profile

Royal Marsden Hospital

The Royal Marsden is one of the world’s most historically significant cancer hospitals. Founded in 1851 as the Free Cancer Hospital by Dr. William Marsden, it is described by the institution as the first hospital in the world dedicated to the study and treatment of cancer.

  • Highest 2026 tier: Tier II
  • Specialty Hospitals
  • 2 ranking categories

Overview

The Royal Marsden is one of the world’s most historically significant cancer hospitals. Founded in 1851 as the Free Cancer Hospital by Dr. William Marsden, it is described by the institution as the first hospital in the world dedicated to the study and treatment of cancer.

The hospital provides specialist cancer care across medical oncology, surgery, radiotherapy, imaging, diagnostics, clinical trials, and supportive cancer services. Its close relationship with The Institute of Cancer Research strengthens its research and translational medicine capabilities.

Royal Marsden Hospital is included in 2 2026 ranking categories. Its highest classification is Tier II. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.

Firm facts

Public identityRoyal Marsden Hospital
Founded1851
Institution typeSpecialty Hospitals institution
HeadquartersLondon, United Kingdom
Primary focusSpecialty Hospitals
Highest 2026 ranking tierTier II

Principal activities

The hospital provides specialist cancer care across medical oncology, surgery, radiotherapy, imaging, diagnostics, clinical trials, and supportive cancer services. Its close relationship with The Institute of Cancer Research strengthens its research and translational medicine capabilities.

Core capability

Specialty Hospitals

Client relevance

Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.

Execution and verification

Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.

Sector and mandate coverage

Primary category

Specialty Hospitals

Institutional context

Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.

Market position

The Royal Marsden’s influence reflects its combination of clinical specialization, scientific heritage, and continuing role in oncology innovation. Its focused cancer mission and long-standing reputation make it one of the most important specialty hospitals in Europe.

Royal Marsden Hospital is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier II.

Competitive context

The relevant peer set varies by category, geography, client segment and mandate. Royal Marsden Hospital should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.

Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.

Leadership and governance

Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.

Corporate and public information

The public-facing organization is identified here as Royal Marsden Hospital. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.

Corporate and disclosure information
OrganizationRoyal Marsden Hospital
HeadquartersLondon, United Kingdom
Verification noteConfirm legal entity, licenses, offices and engagement terms directly before appointment or use.

Rankings and recognition

2026

Tier II

2026

Tier III

Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.

Related Economy analysis

Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:

Sources and data transparency

Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.

  1. Healthcare Ranking — Top 30 Specialty Hospitals 2026 — 2026 inclusion and tier classification.
  2. Healthcare Ranking — Top 30 Centers of Excellence 2026 — 2026 inclusion and tier classification.
  3. The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
  4. The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
  5. The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.

First published: 29 August 2026

Last substantively reviewed: 29 August 2026

Profile scope: Specialty Hospitals

This profile has been compiled from publicly available institutional and editorial sources. The profiled organization does not determine its inclusion, editorial characterization or ranking status. Corrections supported by authoritative documentation may be submitted to The Economy Wiki.